Amrix
NDC Package 16590-596-28
Package Information
Amrix is cyclobenzaprine is used short-term to treat muscle spasms. Marketed by Stat Rx Usa Llc, this product is identified by NDC 16590-596 and is authorized under FDA application NDA021777.
Identification & Billing
- RxCUI: 828353 - cyclobenzaprine HCl 30 MG 24HR Extended Release Oral Capsule
- RxCUI: 828353 - 24 HR cyclobenzaprine hydrochloride 30 MG Extended Release Oral Capsule
- RxCUI: 828353 - cyclobenzaprine hydrochloride 30 MG 24 HR Extended Release Oral Capsule
- RxCUI: 828355 - Amrix 30 MG 24HR Extended Release Oral Capsule
- RxCUI: 828355 - 24 HR cyclobenzaprine hydrochloride 30 MG Extended Release Oral Capsule [Amrix]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 16590 - Stat Rx Usa Llc
- 16590-596 - Amrix
- 16590-596-28 - 28 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
- 16590-596 - Amrix
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (16590-596). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 16590-596-28 identifies a specific commercial package of 28 capsule, extended release in 1 bottle of Amrix, labeled by Stat Rx Usa Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Stat Rx Usa Llc on October 01, 2007. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
Cyclobenzaprine is used short-term to treat muscle spasms. It is usually used along with rest and physical therapy. It works by helping to relax the muscles. This medication is not recommended for use in older adults because they may be at greater risk for side effects while using this drug. Ask the doctor or pharmacist for details.
How is this Stat Rx Usa Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 16590059628. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.